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Background: Microvascular obstruction and endothelial dysfunction have both been linked to tissue hypoperfusion
in falciparum malaria, but their relative contributions to the disease’s pathogenesis and outcome are unknown.
Methods: Microvascular blood flow was quantified in adults with severe falciparum malaria on their admission to
hospital; plasma biomarkers of endothelial function were measured simultaneously. The relationship between these
indices and the patients’ clinical findings and in-hospital course was examined.
Results: Microvascular obstruction was observed in 119/142 (84 %) patients; a median (interquartile range (IQR)) of
14.9 % (6.6–34.9 %) of capillaries were obstructed in patients that died versus 8.3 % (1.7–26.6 %) in survivors (P = 0.039).
The proportion of obstructed capillaries correlated with the estimated parasite biomass (rs = 0.25, P = 0.004) and with
plasma lactate (rs = 0.38, P <0.0001), the strongest predictor of death in the series. Plasma angiopoietin-2
(Ang-2) concentrations were markedly elevated suggesting widespread endothelial activation; the median (IQR) Ang-2
concentration was 21.9 ng/mL (13.4–29.4 ng/mL) in patients that died versus 14.9 ng/mL (9.8–29.3 ng/mL) in
survivors (P = 0.035). Ang-2 concentrations correlated with estimated parasite biomass (rs = 0.35, P <0.001)
and plasma lactate (rs = 0.37, P <0.0001). Microvascular obstruction and Ang-2 concentrations were not significantly
correlated with each other (rs = 0.17, P = 0.06), but were independently associated with plasma lactate (P <0.001 and
P = 0.002, respectively).
Conclusions: Microvascular obstruction and systemic endothelial activation are independently associated with
plasma lactate, the strongest predictor of death in adults with falciparum malaria. This supports the
hypothesis that the two processes make an independent contribution to the pathogenesis and clinical
manifestations of the disease.
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In 1892, five years before Ross identified mosquitoes as
the vector, Marchiafava and Bignami explored the clin-
ical presentations and related pathology of malaria in
their seminal monograph, On Summer-Autumnal Fevers
[1]. They observed that only Plasmodium falciparum
caused ‘malignant malaria’ and presented a post-mortem
series that identified the sequestration of parasitized red
blood cells (pRBCs) in the microcirculation as the
pathological signature of the disease. They highlighted
the relationship between the extent of this sequestration
and the patients’ clinical course, hypothesizing that the
resulting microvascular obstruction was responsible
for many of falciparum malaria’s distinctive clinical
manifestations [1]. In the subsequent 120 years, post-
mortem series have validated their findings, confirming
microvascular obstruction’s central role in the disease’s
pathogenesis [2–5].
More recently the potential pathological contributions
of systemic endothelial activation and dysfunction have
been recognized [6, 7]. These processes result, in part,
from reduced nitric oxide bioavailability and may further
impair microvascular blood flow [8]. Plasma concentra-
tions of a key autocrine mediator of endothelial activa-
tion, angiopoietin-2 (Ang-2), correlate with later death
in falciparum malaria in both adults [7, 9] and children
[10]. Endothelial activation potentiates sequestration
through the upregulation of endothelial ligands [5]; how-
ever, endothelial activation occurs in both mild and
severe falciparum malaria [11] and in many other infec-
tious and non-infectious conditions [12, 13]. And while
endothelial activation in severe malaria is associated with
death independent of total parasite biomass [7], its asso-
ciation with disease severity and mortality independent
of direct measures of microvascular obstruction has
never been evaluated.
This study explored the relationship between micro-
vascular obstruction (assessed directly with orthogonal
polarization spectral (OPS) imaging) and endothelial
activation and function (quantified with plasma bio-
markers) in adults with severe falciparum malaria to
determine their association with the disease’s clinical
manifestations and outcome.
Methods
Clinical, laboratory and OPS imaging data were gathered
prospectively from three groups of adult patients en-
rolled in studies of severe falciparum malaria between
April 2003 and August 2011. OPS imaging data from the
first two groups have been presented previously: the first
group (n = 43) comprised patients enrolled in a study of
OPS imaging in falciparum malaria [14] and the second
group (n = 26) comprised patients enrolled in a study
assessing the fluid management of patients with severefalciparum malaria [15]. The third group (n = 91)
comprised patients enrolled in studies examining ad-
junctive therapies in falciparum malaria and pathophysi-
ology [16, 17]. Their OPS imaging data was analysed
specifically for this series.
All patients were hospitalized at Chittagong Medical
College Hospital, Bangladesh or Ispat General Hospital,
Rourkela, India. Malaria transmission is seasonal at both
sites. Falciparum malaria was diagnosed if asexual forms
of P. falciparum were present on a blood film. When ex-
pert microscopy was not available immediately, patients
were enrolled if an immunochromatographic rapid diag-
nostic test (Paracheck Pf, Orchid Biomedical Systems,
Goa, India) was positive, and P. falciparum infection was
confirmed later by microscopy of a simultaneously col-
lected blood slide.
All patients satisfied a strict definition of severe
falciparum malaria. Patients had at least one of the
following modified World Health Organization (WHO) cri-
teria: cerebral malaria (Glasgow Coma Scale (GCS) <11);
severe anaemia (haematocrit <20 % with a parasite
count >100,000/mm3); renal failure (blood urea nitro-
gen >21.4 mmol/L or serum creatinine level >265 μmol/L);
pulmonary oedema (oxygen saturation <90 % and
bibasal crepitations); generalized convulsions; acidosis
(venous bicarbonate <15 mmol/l); hyperparasitaemia
(peripheral parasitaemia >10 %); hyperlactataemia (venous
lactate >4 mmol/L); jaundice (bilirubin >42.8 mmol/L
and a parasite count >100,000/mm3); hypoglycaemia
(glucose <2.2 mmol/L); and spontaneous bleeding or
shock (systolic blood pressure <80 mmHg with cool
extremities). Multi-organ dysfunction was defined as the
presence of more than one of these criteria (excluding
hyperparasitaemia), although in this definition coma and
seizures were classified as one criterion, as were acidosis
and hyperlactatemia; if data were missing, the patient
was presumed not to satisfy that criterion. Patients were
excluded if they were <13 years of age or if they had re-
ceived parenteral antimalarial treatment for >24 h before
enrolment.
On enrolment, a standardized history was taken, a
physical examination performed and venous blood col-
lected. Nine patients in the first group were treated with
intravenous quinine but all the remaining patients re-
ceived intravenous artesunate. Patients received standard
supportive care as per contemporary WHO treatment
guidelines [18–20], although the availability of support-
ive therapies including mechanical ventilation and renal
replacement therapy (RRT) was limited, particularly in
the earlier study years.
The absolute peripheral parasite count (parasites/μl)
was calculated on admission from the thin blood film
using the formula: parasite count/1,000 RBC × 125.6 ×
haematocrit (%) or from the thick film using the formula:
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indices were measured at field sites using a portable
handheld analyser (i-Stat®, Abbott, Princeton, NJ, USA).
For other indices plasma samples were processed and
stored at −80 °C for further analysis in Bangkok,
Thailand and Darwin, Australia. Plasma Plasmodium
falciparum histidine-rich protein 2 (PfHRP2) was mea-
sured using ELISA (Cellabs, Sydney, New South Wales,
Australia), according to the manufacturer’s instructions
with minor modifications as described previously [21].
Ang-2 and vascular endothelial growth factor (VEGF)
were also measured using ELISA (R&D Systems,
Minneapolis, MN, USA). L-arginine, the substrate for
endothelial cell NO synthase, and asymmetric dimethylar-
ginine (ADMA), an endogenous inhibitor of NO syn-
thase, were measured using high performance liquid
chromatography as described previously [22]. As there
are no published reference ranges for these measures of
endothelial function in the normal Bangladeshi popula-
tion, samples were collected - and a reference range
determined - from 45 healthy volunteers. It was not
possible to export Indian plasma and so the 15 Indian
patients did not have their Ang-2, L-arginine, VEGF or
ADMA measured.
OPS recording and analysis
Video recordings of the microcirculation in the rectal
mucosa were collected at the time of study enrolment,
with an OPS device (either Cytoscan® from Cytometrics,
Heathpark, Honiton, Devon, UK or Microscan® from
Microvision Medical, Amsterdam, The Netherlands),
which was applied gently to prevent pressure artefact.
The video recordings were imported into Final Cut Pro
(version 3.0.2, Apple, Cupertino, CA, USA), and were
analysed using image analysis software (OpenLab 3.1.5,
Improvision, Waltham, MA, USA). Separate recordings
of at least 10 seconds were collected at three different
sites on the rectal mucosa of all patients. Blood flow was
measured by tracing the movement of individual eryth-
rocytes over time; only erythrocytes that could be
tracked over three successive frames were assessed.
Obstructed microvascular blood flow was defined as a
blood flow velocity <100 μm/s. Assessment was per-
formed on three occasions: two reviewers (JH and PC)
separately analysed the recordings from the first group
blinded to patient details and outcome in 2006. In this
group of patients a mean of 50 (95 % confidence interval
(CI) 37–62) capillaries were assessed. In 2009 the re-
cordings from the second group were analysed by the
clinician (JH) who had managed the patients a year pre-
viously (although patients were identified only by a pa-
tient code and the results were validated by blinded
reviewers (RJM and HK) [15]). In 2013 the third group
was analysed by a single reviewer (JH) blinded to patientdetails and outcome. In the second and third group of
patients the blood flow in 60 capillaries was assessed in
all patients.
Statistics
Data were collected and analysed using statistical soft-
ware (Stata version 10, StataCorp, College Station, TX,
USA). Associations between continuous variables were
examined using Spearman’s rank correlation coefficient.
Groups were compared using the Kruskal-Wallis test,
the chi-squared and Fisher’s exact test. The strongest
predictor of death was identified using backward step-
wise estimation in a logistic regression model with ran-
dom effects for study year. All risk factors that were
significant in the univariate analysis at P <0.05 were
included in the initial model (Table 1). Only variables
that were significant at P <0.05 were retained in the final
model.
Logistic regression models were used to quantify the
odds of death with study and year fitted as a random
effect to account for clustering and, in the case of the
OPS imaging data, any unobserved heterogeneity due to
inter-rater variability. An interaction term for plasma
Ang-2 concentration and microvascular obstruction was
created to determine whether their association with dis-
ease severity and death could be interpreted without
effect modification.
Ethics review
All of the studies from which data were analysed re-
ceived prospective ethical approval from the Bangladeshi
Medical Research Council, the institutional ethical board
of Ispat General Hospital and the Oxford Tropical
Medicine Research Ethical Committee. ISRCTN registra-
tion numbers: ISRCTN 27232551, ISRCTN 20156397
and ClinicalTrials.gov identifier NCT00692627. Family
members provided written informed consent, via a local




OPS imaging data were available for 160 patients (69 pre-
viously reported [14, 15] and 91 new patients). Poor qual-
ity images precluded reliable assessment of 18 of the new
patients’ films (Fig. 1), leaving a total of 142 patients’ re-
cordings for analysis (Table 1). Overall 47 (33 %) of these
142 patients died despite the prompt use of parenteral
anti-malarial therapy and management by dedicated
study clinicians. Patients presented late in the course of
their illness: the median (interquartile range (IQR)) dur-
ation of symptoms was 7 (5–8) days by which stage
most (n = 90 (63.4 %)) had multi-organ dysfunction.
Patients with multi-organ dysfunction on admission
Table 1 Baseline characteristics of the patients and association with outcome
Variable N All n = 142 Survivors n = 95 Deaths n = 47 Pb
Age (years) 141 35 (25–45) 31 (24–46) 35 (25–45) 1.00
Sex (% male) 141 71 % 74 % 64 % 0.24
Glasgow Coma Score 142 9 (6–13) 10 (8–14) 8 (4–10) <0.001
Mean arterial pressure (mmHg) 140 82 (72–93) 80 (72–90) 83 (71–97) 0.32
Respiratory rate (breaths/min) 137 30 (26–36) 30 (25–36) 32 (28–40) 0.02
Oxygen saturation (%) 138 96 (94–97) 96 (94–97) 96 (93–97) 0.39
Temperature (°C) 142 38 (37.2– 38.9) 37.9 (37.2–38.6) 38.2 (37.1–39.2) 0.25
Heart rate (beats/min) 138 109 (96–122) 107 (93–119) 117 (102–132) 0.02
Plasma sodium (mmol/L) 140 135 (132–139) 135 (132–139) 135 (132–140) 0.4
Plasma potassium (mmol/L) 139 4 (3.6–4.5) 3.9 (3.6–4.4) 4.2 (3.8–4.6) 0.05
Blood urea nitrogen (mmol/L) 141 14.3 (8.8–24.1) 12.9 (8.2 –22) 17.9 (10.3–29.3) 0.02
Plasma creatinine (μmol/L) 140 136 (88–220) 122 (86–193) 150 (97–300) 0.16
Plasma lactate (mmol/L) 141 4.3 (2.6–6.6) 3.7 (2.2–5.1) 6.3 (4.1–10) <0.001
Base deficit (meq/L) 140 8 (3–12) 6.5 (2–10) 12 (5–17) <0.001
White cell count (x 109/L) 104 8.5 (6.1–10.9) 8 (5.4–10) 10.9 (7.2–11.5) 0.002
Haemoglobin (g/dL) 139 9.6 (7.8–11.3) 9.3 (8–11.2) 10.2 (7–12) 0.64
Platelet count (x 109/L) 107 36 (21–66) 43 (24–87) 27 (15–41) 0.02
Microvascular obstruction (%)a 142 11.9 (3–26.7) 8.3 (1.7–26.6) 14.9 (6.6–34.9) 0.039
PfHRP2 (ng/mL) 135 2,268 (960–4,789) 2,151 (881–4,261) 2,584 (1,075–5,946) 0.17
Parasite count (parasites/uL) 134 67,133 (20,253–274,499) 97,968 (11,681–310,546) 60,288 (24,116–176,845) 0.59
Angiopoietin-2 (ng/mL) 126 19.1 (10.8–29.1) 14.9 (9.8–29.3) 21.9 (13.4–29.4) 0.035
L-arginine (μmol/L) 126 59.6 (44.3–79.9) 59.6 (44.1–77.8) 60.1 (38.3–71.5) 0.78
ADMA (μmol/L) 126 0.77 (0.58–1.01) 0.77 (0.57–0.99) 0.77 (0.58–1.18) 0.58
L-arginine: ADMA ratio 126 73.3 (59.8–90.6) 72.7 (62.7–89.6) 73.5 (58.6–90.7) 0.43
VEGF (pg/mL) 125 27.3 (0–59.2) 24.9 (0–54.7) 34.1.7 (0–64.9) 0.93
Plasma glucose (mmol/L) 137 6.6 (5–9.2) 6.8 (5.3–9.3) 6.2 (3.6–9.1) 0.07
All values represent the median (interquartile range) unless otherwise stated. aDetermined using orthogonal polarization spectral imaging. The percentage of capillaries
with a blood flow of <100 μm/s. bStatistical significance for a difference between survivors and non-survivors. ADMA: Asymmetric dimethylarginine; PfHRP2: Plasmodium
falciparum histidine-rich protein 2; VEGF: Vascular endothelial growth factor
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with single organ involvement (8/52 (15 %), P = 0.001).
Death also varied by study year (range 8.3–60 %, P = 0.02,
degrees of freedom = 8). The highest case fatality
rates occurred in the first two study years (60 % and
52.3 %, respectively) when few patients had access to
RRT and mechanical ventilation. In the ensuing years,
when this support was more accessible, the median
(IQR) case fatality rate was 27.9 % (12.8–36.1). How-
ever, using a stepwise model, admission plasma lactate
was identified as the strongest predictor of death (ad-
justed odds ratio (AOR): 1.39, 95 % CI 1.15–1.68).
When controlled for disease severity (plasma lactate
on admission), the association between death and
multi-organ involvement and death and study year
was no longer significant (P = 0.07 and P = 0.06,
respectively).Microcirculation
On admission, 119/142 (84 %) patients had obstructed
microvascular flow visualized with OPS imaging. The
median (IQR) percentage of obstructed capillaries was
greater in the patients who died (14.9 % (6.6–34.9)) than
in survivors (8.3 % (1.7–26.6)) (P = 0.039) (Fig. 2). The
relationship remained significant when controlled for
inter-rater variability (AOR: 1.03, 95 % CI 1.00–1.05,
P = 0.026) and study year (AOR: 1.03, 95 % CI 1.00–
1.05, P = 0.027).
There was a higher proportion of obstructed capillaries
in patients with a significantly elevated plasma lactate
(≥4 mmol/L, the WHO cut-off for elevated lactate)
(P = 0.0001) (Fig. 3), in patients with multi-organ
dysfunction (P = 0.002) (Fig. 4) and in patients with acute
kidney injury ((AKI), plasma creatinine ≥176 μmol/L)
(P = 0.006) (Fig. 5). The percentage of obstructed
Fig. 1 Selection of OPS imaging data for analysis. αThere were 91 new patients with OPS imaging data for analysis. Eighteen of these patients
had poor quality images that precluded analysis: six had pressure artefact, three had a recording that was too short and poorly located, three had
a recording that was too short, two had a recording that was short and had pressure artefact, one had unfocussed images, one was poorly
located, one had pressure artefact and was poorly located, and one was short, had pressure artefact and was poorly located. These eighteen
patients were excluded from the analysis. βOne patient had insufficient specimen for a VEGF determination. γOne Bangladeshi patient had no
admission specimen; the 15 Indian patients could not have plasma exported. ADMA: Asymmetric dimethylarginine; Ang-2: Angiopoietin-2; OPS:
Orthogonal polarization spectral; VEGF: Vascular endothelial growth factor
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parasite biomass (rs = 0.25, P = 0.004), and more
weakly with peripheral parasite count (rs = 0.19, P = 0.027).
There was no significant relationship between the
rectal OPS findings and the presence of coma (GCS <11)
(P = 0.14) (Fig. 6). There was no statistically signifi-
cant association between microvascular obstruction
and plasma Ang-2 concentrations (rs = 0.17, P =
0.057), or any of the other markers of endothelial
function.Fig. 2 Association between microvascular obstruction, endothelial activatioMarkers of endothelial activation and dysfunction
There was marked derangement of all the measures of
endothelial activation and function on admission. Plasma
Ang-2 concentrations were higher in the patients with
severe malaria (median (IQR) 19.1 (10.8–29.1) ng/mL) than
in healthy controls (median (IQR) 1.6 (1.4–2.3) ng/mL)
(P = 0.0001). Admission plasma Ang-2 concentrations
were significantly greater in patients who died (median
(IQR) 21.9 (13.4–29.4) ng/mL) than in survivors (median
(IQR) 14.9 (9.8–29.3) ng/mL) (P = 0.035) and weren and patient outcome
Fig. 3 Association between microvascular obstruction, endothelial activation and plasma lactate
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(P = 0.001) (Fig. 3), multi-organ dysfunction (P = 0.004)
(Fig. 4), AKI (P = 0.0001) (Fig. 5) and estimated parasite
biomass (rs = 0.35, P <0.001). Admission plasma Ang-2
concentrations were significantly lower in the patients with
coma on admission than in the non-comatose patients
(P = 0.002) (Fig. 6).
Admission plasma ADMA concentrations were ele-
vated in the majority of patients (median (IQR) 0.75
(0.59–1.03) μmol/L versus 0.55 (0.49–0.59) μmol/L in
healthy controls (P = 0.0001)), and correlated with
Ang-2 (rs = 0.41, P <0.001) and plasma lactate (rs = 0.22,
P = 0.01), but not death (P = 0.31). Plasma L-arginine
concentrations were decreased on admission in the major-
ity of patients (median (IQR) 59.6 (44.3–79.9) pg/mL in pa-
tients versus 141 (116.6–161.6) pg/mL in healthy controlsFig. 4 Association between microvascular obstruction, endothelial activatio(P = 0.0001)), and correlated with Ang-2 (rs = 0.31,
P <0.001) and plasma lactate (rs = 0.29, P = 0.001),
but not death (P = 0.56). Median admission plasma
VEGF concentrations were generally decreased (median
(IQR) 27.3 (0–59.2) pg/mL versus 79.2 (44.0–114.0) pg/mL
in healthy controls (P = 0.001)), and were inversely corre-
lated with Ang-2 (rs = −0.37, P <0.001), parasite biomass
(rs = −0.31, P <0.001) and plasma lactate (rs = −0.41,
P <0.001). However, after controlling for parasite bio-
mass, the relationship between VEGF and plasma lactate
was no longer significant. There was no association be-
tween plasmaVEGF and death (P = 0.93).
Multivariable regression analysis
When combined in a logistic regression model with ran-
dom effects for study year and inter-rater variability, an and multi-organ dysfunction
Fig. 5 Association between microvascular obstruction, endothelial activation and acute kidney injury
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microvascular obstruction, Ang-2 concentration and
death could not be demonstrated (P = 0.06 for both,
n = 126). The inclusion of an interaction term for
microvascular obstruction and plasma Ang-2 concen-
trations was not significant (P = 0.88) and did not
improve the model fit.
In a linear regression model with plasma lactate as the
dependent variable, both microvascular obstruction and
plasma Ang-2 concentrations were significant inde-
pendent risk factors for increased plasma lactate (both
P <0.001). In a model (n = 109) controlling for other
factors that influence end organ perfusion, micro-
vascular obstruction (P <0.001) and plasma Ang-2
concentration (P = 0.002) had a stronger correlationFig. 6 Association between microvascular obstruction, endothelial activatiowith plasma lactate than did estimated parasite bio-
mass (P = 0.01), haemoglobin (P = 0.05), arterial oxygen
saturation (P = 0.08), age (P = 0.09) or mean arterial blood
pressure (P = 0.58).
Discussion
This detailed clinical study provides further support for
the belief that microvascular obstruction plays a funda-
mental role in the pathogenesis of severe falciparum
malaria. Previous studies of patients with malaria have
linked the degree of microvascular obstruction to disease
severity [14, 15], but this larger series was also able to
establish an association with the patients’ subsequent
death; the demonstration of an in vivo association be-
tween microvascular obstruction and the presence ofn and coma
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novel. The correlation between the OPS imaging results
and the estimated total parasite burden suggests that the
OPS imaging findings are representative of the seques-
tration that is present throughout the body in falciparum
malaria and emphasises the potential utility of OPS
imaging, given that it is able to assess a patient’s micro-
circulation during life. Plasma measures of endothelial
activation and function were markedly deranged, with
Ang-2 concentrations also correlating with the estimated
parasite burden and outcome.
Plasma lactate, a measure of tissue hypoperfusion, was
the strongest predictor of death in the series. As micro-
vascular obstruction and endothelial activation are
thought to lead to organ dysfunction through tissue hy-
poperfusion [7, 23], the finding that they were independ-
ently associated with plasma lactate is consistent with
the hypothesis that they both have a causative role in
the disease pathogenesis of the disease. The fact that
microvascular obstruction and endothelial activation
correlated more strongly with plasma lactate than in-
dices such as blood pressure, oxygen saturation and
haemoglobin highlights the pathological significance
of the microcirculation in falciparum malaria.
OPS imaging has been used to assess the microcircula-
tion in a variety of conditions [24–26]. Bacterial sepsis
has been studied in the most detail and, as in falciparum
malaria, measures of microvascular function are
stronger predictors of outcome than a patient’s sys-
temic hemodynamic status [15, 26]. However, there are
clear differences in the OPS imaging findings between
the two conditions. In patents with bacterial sepsis there
is reduced capillary density and intermittent or absent
perfusion in vessels of all sizes, changes which are revers-
ible with the application of acetylcholine [26, 27]. In con-
trast, in severe falciparum malaria the striking finding is
one of numerous persistently obstructed capillaries, an
appearance which exactly replicates the histopathological
findings at post-mortem examination [2–5]. These OPS
findings also accord with the biochemical changes seen
in the two conditions: in falciparum malaria elevated lac-
tate: pyruvate ratios suggest anaerobic metabolism due to
tissue hypoxia from an obstructed microcirculation ra-
ther than the accelerated aerobic glycolysis that is seen in
sepsis [28, 29].
While the degree of visualized microvascular obstruc-
tion in the rectal mucosa correlated with many measures
of disease severity, there was no association with coma
depth. This presumably reflects the marked heterogen-
eity that is seen in the distribution of sequestration in
different organs of the body [4], different parts of the
brain [30, 31] and even in different vessels from the
same area of the brain [31]. While the clinical presen-
tation of cerebral malaria is correlated with the extentof cerebral sequestration on autopsy [4, 32, 33], the
pathogenesis of cerebral malaria is generally believed
to be more complex than simply resulting from direct
hypoperfusion [31]; other factors including congestion
and axonal injury are likely to contribute [32, 34].
The neuroanatomical location of pathological changes
is also probably critical: the ascending reticular acti-
vating system controls consciousness and the extent
to which these neurons are involved will determine
coma depth [35].
Plasma Ang-2 concentrations were associated with dis-
ease severity and death as in other series of severe falcip-
arum malaria [7, 9, 10] and studies of other critical
illnesses [36, 37]. As with many biomarkers, it has been
unclear whether elevations in Ang-2 are the cause or re-
sult of disease [38]. However, clinical studies of patients
with bacterial sepsis have shown that elevations in
plasma Ang-2 concentrations precede the appearance of
end-organ injury and that serum from patients with sep-
sis disrupts the integrity of monolayers of endothelial
cells in vitro via an Ang-2-dependent mechanism, sug-
gesting that Ang-2 may be directly pathogenic [37]. Al-
though Ang-2 has a variety of context-dependent effects
on endothelial cells, by enhancing endothelial activation
and increasing vascular permeability it is thought to play
an important role in the pathogenesis of acute lung in-
jury and multi-organ failure [36, 39], both of which are
complications of falciparum malaria with a high attribut-
able mortality [20]. Plasma Ang-2 concentrations were
higher in the patients in this series with multi-organ dys-
function and while there was no clear association with
acute lung injury, this was an infrequent finding in the
series (six cases, only four of whom had an Ang-2 level
available for analysis).
Nitric oxide is essential for the regulation of micro-
vascular blood flow and inhibits the release of Ang-2
and other pro-inflammatory and vasoactive molecules
[40, 41], however nitric oxide bioavailability is reduced
in patients with falciparum malaria [6]. This is thought
to result from hypoargininaemia [6], decreased nitric
oxide synthase expression [42], quenching of nitric oxide
by haemolysis-related cell-free haemoglobin [43] and im-
paired metabolism and clearance of the endogenous ni-
tric oxide synthase inhibitor ADMA [44]. As endothelial
nitric oxide concentrations decline, there is loss of vaso-
dilatory tone which results in tissue hypoperfusion, lactic
acidosis and organ dysfunction [8, 41]. Falling nitric
oxide concentrations also lead to endothelial activation
and the upregulation of endothelial receptors - including
pRBC ligands like ICAM-1 - which facilitates pRBC
cytoadherence [45]. This may cause further decreases in
local nitric oxide concentrations, as the principal signal
for nitric oxide production from the resting endothelium
is the shear stress of flowing blood. Microvascular
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tissue hypoxia, another strong stimulus for endothe-
lial activation [46].
It is clear to see how this might evolve into a vicious
cycle, but in this series plasma Ang-2 concentrations did
not correlate strongly with the visualized obstruction.
This suggests that there is either a temporal dissociation
between Ang-2 release and microvascular sequestration,
that elevated Ang-2 concentrations are not the result of
a simple, direct interaction between pRBCs and the
endothelium, or that our statistical analysis is limited by
the fact that we are comparing a local phenomenon
(directly visualized microvascular appearances) with a
systemic one (circulating plasma Ang-2 levels).
This study highlights the importance of microvascular
obstruction in the unique presentation of falciparum
malaria. Endothelial activation is present in many infec-
tious and non-infectious conditions which lack falciparum
malaria’s distinctive clinical and pathological findings
[12, 13]. This includes vivax malaria [47, 48], a condition
in which microvascular obstruction is largely absent [49]
and organ failure and death less frequent [50]. The associ-
ation between microvascular obstruction and the clinical
manifestations of falciparum malaria emphasizes the rela-
tive clinical significance of the parasites in the RBCs that
are obstructing the microcirculation when compared with
circulating parasites which are represented by the periph-
eral parasitaemia [23]. For clinicians this means focusing
primarily on a patient’s signs and symptoms and not being
falsely reassured by a ‘low’ peripheral parasite count.
When all patients with P. falciparum infection are consid-
ered, patients with higher peripheral parasite counts have
a greater risk of complicated disease; however, in this
series, where only patients with severe disease were en-
rolled, the median circulating parasite count was actually
higher in survivors.
Plasma levels of VEGF were significantly decreased in
this series and, as in previous studies, had an inverse
correlation with disease severity [7]. This is in marked
contrast to findings in murine models and argues against
a role for excessive VEGF in pathogenesis of severe mal-
aria. The inverse association between parasite biomass
and VEGF is hypothesized to result from the absorption
and accumulation of host VEGF within the parasito-
phorous vacuole by mature P. falciparum parasites,
sequestered within the microvasculature [7]. VEGF
stimulates the release of nitric oxide and upregulates
the expression of nitric oxide synthase, thus the de-
creased VEGF concentrations provide another mech-
anism for decreased nitric oxide bioavailability. The
significantly lower plasma Ang-2 concentrations in
comatose patients replicates a similar finding in a
previous Vietnamese study [9] and requires further
evaluation.Conclusion
In conclusion, microvascular obstruction and systemic
endothelial activation are both associated with tissue hy-
poperfusion, organ dysfunction and death in adults with
falciparum malaria. These associations are consistent
with the hypothesis that both processes play a significant
role in the pathogenesis of the disease. Interventions
which target either pathway may have therapeutic
potential.
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